Physician profile
Timothy James Koll
NPI 1154403194
$4,228.28
in general payments reported to CMS, 2019-2025
7 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Oral and Maxillofacial Pathology provider received nationally (typical 2025 total: $90.97).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.76 · 2020: $44.32 · 2021: $14.80 · 2022: $44.96 · 2023: $3,645 · 2024: $160 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Entertainment: $563 · Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Entertainment | $563.48 |
| Food and Beverage | $467.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply LLC | $3,000.00 | 2023 | |
| Keystone Dental INC. | $765.92 | 2023-2025 | |
| Dentsply Sirona INC | $308.36 | 2019-2025 | Implant Dentistry, Astra Tech Implant System |
| Straumann USA LLC | $87.91 | 2022-2023 | |
| Pacira Pharmaceuticals Incorporated | $24.71 | 2019 | |
| Biohorizons Implant Systems INC. | $21.00 | 2023 | Biohorizons |
| Stryker Corporation | $20.38 | 2024 | Na, Stryker Varispeed, Vsp System, Vsp Cranial |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Koll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.